Podiatrists in Newnan, GA Accepting Medicare

5 Podiatrists found. Showing 1 - 5

Ruchi R Ram, DPM Podiatrist Medicare: Medicare Enrolled Practice Location: 110 Oak Hill Blvd Ste 100, Newnan, GA 30265 Phone: 770-415-0594    Fax: 833-645-2187

Village Podiatry Group Llc Podiatrist Medicare: Not Enrolled in Medicare Practice Location: 110 Oak Hill Blvd Ste 100, Newnan, GA 30265 Phone: 770-415-0594    Fax: 833-645-2187

Crossroads Podiatry & Ingrown Nail Center Inc Podiatrist Medicare: Medicare Enrolled Practice Location: 3231 Hwy 34 East, Suite C, Newnan, GA 30265 Phone: 770-251-8940    Fax: 770-251-5685

Ankle And Foot Center Of Georgia,llc Podiatrist - Foot & Ankle Surgery Medicare: Not Enrolled in Medicare Practice Location: 2700 Highway 34 E, Bldg 200, Newnan, GA 30265 Phone: 770-755-1949    Fax: 770-783-0294

Dr. Everett J Mason Iii, DPM Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 3231 Hwy 34, Ste C, Newnan, GA 30265 Phone: 770-251-8940    Fax: 770-251-5685

News Archive

Rudolf Jaenisch honored with 2015 March of Dimes Prize in Developmental Biology

Rudolf Jaenisch, MD, who laid the groundwork for the development and use of induced pluripotent stem (iPS) cells - stem cells derived directly from adult tissue - to potentially treat and cure a variety of human diseases, has received the 20th anniversary March of Dimes Prize in Developmental Biology.

Noninvasive tests for cirrhosis may help to avoid liver biopsy

Newer ultrasound and magnetic resonance (MR) imaging tests yield encouraging initial results in diagnosing fibrosis (scarring) and cirrhosis of the liver, according to three studies in the October issue of the journal Clinical Gastroenterology and Hepatology.

Ingen Technologies provides update on Proxy vote and plans up-list onto OTCBB

Ingen Technologies, Inc., is an ISO Certified and FDA Registered medical device manufacturer with an emerging new medical product line for the respiratory market worth an estimated $4 billion in the U.S., and $8 billion globally. The company sells their patented and proprietary Oxyview and SMART Nasal Cannula along with their most recent released INGEN Pulse Oximeter. Today the company announced Proxy results and growth plans.

GTx reports positive results from toremifene Phase III clinical trial

GTx, Inc. announced today that in the Phase III clinical trial evaluating toremifene 80 mg for the reduction of fractures and treatment of other estrogen deficiency side effects in men with prostate cancer on androgen deprivation therapy (ADT), toremifene treatment demonstrated an improved benefit/risk ratio in men less than 80 years of age. The data were presented yesterday at the 2010 Annual Meeting of the American Society of Clinical Oncology in Chicago.

Read more Medical News

› Verified 4 days ago